Age-related macular degeneration (AMD) is a degenerative disease of the macula, the region of the retina that is responsible for central vision. It is the leading cause of irreversible vision loss as people age in the United States.
1 In its later stages, AMD affects about 7% of people between the ages of 75 and 84 years.
2 Early and intermediate stages of AMD, which increase the risk of developing advanced AMD,
3 are even more common, affecting about one quarter of people older than 65 years.
2 Because there is no cure for this condition and limited treatment is available to slow its progression, and there are no established means of prevention, it is important to identify modifiable risk factors that may reduce disease occurrence or prevent progression to the late stages of AMD. The pathogenesis of AMD is likely to involve a complex interaction of cellular and vascular factors, which may be promoted by light damage,
4 oxidative stress,
5 and inflammation.
6